SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE
The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types. La présente invention concerne un procédé de t...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WITTRUP, Karl Dane OPEL, Cary Francis KWAN, Byron Hua COCHRAN, Jennifer R MOYNIHAN, Kelly Dare IRVINE, Darrell J |
| description | The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.
La présente invention concerne un procédé de traitement du cancer à l'aide d'une combinaison d'IL-2 (par exemple, IL-2 à pharmacocinétique prolongée), d'une protéine de fusion Fc liant l'intégrine, et d'un vaccin contre le cancer. Les procédés de l'invention peuvent être utilisé pour traiter un large éventail de types de cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2017139570A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2017139570A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2017139570A83</originalsourceid><addsrcrecordid>eNqNyr0KwjAQAOAuDqK-w4Grgf4g1TGml_bAXiS9WpxKKXESLdT3RwQfwOlbvmU0NjdGX1IjZEDa2nkQj1pqZIGOpAI6q3QHmoFYsPTE6kRcEJfKGrBtQ47h4p0g8bcVoMFoNujhqo0hZlxHi_vwmMPm5yraWhRTqTC9-jBPwxie4d13Lo2TPMmO-zzWh-y_9QG_5zS-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE</title><source>esp@cenet</source><creator>WITTRUP, Karl Dane ; OPEL, Cary Francis ; KWAN, Byron Hua ; COCHRAN, Jennifer R ; MOYNIHAN, Kelly Dare ; IRVINE, Darrell J</creator><creatorcontrib>WITTRUP, Karl Dane ; OPEL, Cary Francis ; KWAN, Byron Hua ; COCHRAN, Jennifer R ; MOYNIHAN, Kelly Dare ; IRVINE, Darrell J</creatorcontrib><description>The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.
La présente invention concerne un procédé de traitement du cancer à l'aide d'une combinaison d'IL-2 (par exemple, IL-2 à pharmacocinétique prolongée), d'une protéine de fusion Fc liant l'intégrine, et d'un vaccin contre le cancer. Les procédés de l'invention peuvent être utilisé pour traiter un large éventail de types de cancer.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180712&DB=EPODOC&CC=WO&NR=2017139570A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180712&DB=EPODOC&CC=WO&NR=2017139570A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WITTRUP, Karl Dane</creatorcontrib><creatorcontrib>OPEL, Cary Francis</creatorcontrib><creatorcontrib>KWAN, Byron Hua</creatorcontrib><creatorcontrib>COCHRAN, Jennifer R</creatorcontrib><creatorcontrib>MOYNIHAN, Kelly Dare</creatorcontrib><creatorcontrib>IRVINE, Darrell J</creatorcontrib><title>SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE</title><description>The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.
La présente invention concerne un procédé de traitement du cancer à l'aide d'une combinaison d'IL-2 (par exemple, IL-2 à pharmacocinétique prolongée), d'une protéine de fusion Fc liant l'intégrine, et d'un vaccin contre le cancer. Les procédés de l'invention peuvent être utilisé pour traiter un large éventail de types de cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAQAOAuDqK-w4Grgf4g1TGml_bAXiS9WpxKKXESLdT3RwQfwOlbvmU0NjdGX1IjZEDa2nkQj1pqZIGOpAI6q3QHmoFYsPTE6kRcEJfKGrBtQ47h4p0g8bcVoMFoNujhqo0hZlxHi_vwmMPm5yraWhRTqTC9-jBPwxie4d13Lo2TPMmO-zzWh-y_9QG_5zS-</recordid><startdate>20180712</startdate><enddate>20180712</enddate><creator>WITTRUP, Karl Dane</creator><creator>OPEL, Cary Francis</creator><creator>KWAN, Byron Hua</creator><creator>COCHRAN, Jennifer R</creator><creator>MOYNIHAN, Kelly Dare</creator><creator>IRVINE, Darrell J</creator><scope>EVB</scope></search><sort><creationdate>20180712</creationdate><title>SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE</title><author>WITTRUP, Karl Dane ; OPEL, Cary Francis ; KWAN, Byron Hua ; COCHRAN, Jennifer R ; MOYNIHAN, Kelly Dare ; IRVINE, Darrell J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2017139570A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WITTRUP, Karl Dane</creatorcontrib><creatorcontrib>OPEL, Cary Francis</creatorcontrib><creatorcontrib>KWAN, Byron Hua</creatorcontrib><creatorcontrib>COCHRAN, Jennifer R</creatorcontrib><creatorcontrib>MOYNIHAN, Kelly Dare</creatorcontrib><creatorcontrib>IRVINE, Darrell J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WITTRUP, Karl Dane</au><au>OPEL, Cary Francis</au><au>KWAN, Byron Hua</au><au>COCHRAN, Jennifer R</au><au>MOYNIHAN, Kelly Dare</au><au>IRVINE, Darrell J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE</title><date>2018-07-12</date><risdate>2018</risdate><abstract>The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.
La présente invention concerne un procédé de traitement du cancer à l'aide d'une combinaison d'IL-2 (par exemple, IL-2 à pharmacocinétique prolongée), d'une protéine de fusion Fc liant l'intégrine, et d'un vaccin contre le cancer. Les procédés de l'invention peuvent être utilisé pour traiter un large éventail de types de cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_WO2017139570A8 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINNE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T19%3A52%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WITTRUP,%20Karl%20Dane&rft.date=2018-07-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2017139570A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |